Healthia Ltd (ASX: HLA) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Healthia Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $272.77 million
P/E Ratio 35.84
Dividend Yield 2.01%
Shares Outstanding 126.87 million
Earnings per share 0.061
Dividend per share 0.06
Year To Date Return 76.70%
Earnings Yield 2.79%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Healthia Ltd (ASX: HLA)
Latest News

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
07 Sep 2021 $0.0250 100.00% Final 27 Oct 2021
02 Mar 2021 $0.0200 100.00% Interim 23 Mar 2021
08 Sep 2020 $0.0200 100.00% Final 28 Sep 2020

HLA ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Healthia Ltd

Healthia Ltd is an Australian holding company that operates in the podiatry, physiotherapy, and optometry industry. The company through its holdings owns and operates the My FootDr Podiatry Clinics, Allsports Physiotherapy & Sports Medicine Clinics, iOrthotics, and others. The podiatry division provides podiatry services and podiatry-related services including the manufacturing and sale of orthotics and podiatry-related products, the Physiotherapy division provides physiotherapy and specialty hand therapy services, and the Optometry division provides optometry services. The majority of the revenue is generated from Australia.

HLA Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
03 Dec 2021 $2.17 $0.07 3.33% 57,597 $2.15 $2.17 $2.11
02 Dec 2021 $2.10 $-0.04 -1.87% 76,089 $2.14 $2.16 $2.10
01 Dec 2021 $2.14 $-0.01 -0.47% 75,172 $2.12 $2.17 $2.12
30 Nov 2021 $2.15 $0.05 2.38% 51,677 $2.09 $2.15 $2.09
29 Nov 2021 $2.10 $-0.03 -1.41% 428,474 $2.05 $2.14 $2.04
26 Nov 2021 $2.13 $-0.03 -1.39% 169,512 $2.13 $2.13 $2.09
25 Nov 2021 $2.16 $0.00 0.00% 147,339 $2.15 $2.16 $2.10
24 Nov 2021 $2.16 $0.04 1.89% 152,437 $2.12 $2.16 $2.09
23 Nov 2021 $2.12 $0.00 0.00% 337,336 $2.09 $2.13 $2.09
22 Nov 2021 $2.12 $-0.03 -1.40% 28,617 $2.16 $2.16 $2.08
19 Nov 2021 $2.15 $0.00 0.00% 342,442 $2.14 $2.19 $2.10
18 Nov 2021 $2.15 $0.11 5.39% 552,381 $2.05 $2.16 $2.04
17 Nov 2021 $2.04 $0.07 3.55% 153,154 $2.01 $2.05 $1.99
16 Nov 2021 $1.97 $-0.03 -1.50% 18,858 $2.00 $2.03 $1.97
15 Nov 2021 $2.00 $0.10 5.26% 141,625 $1.97 $2.00 $1.95
12 Nov 2021 $1.90 $0.00 0.00% 184,683 $1.92 $1.92 $1.88
11 Nov 2021 $1.90 $-0.04 -2.06% 226,763 $1.95 $1.95 $1.89
10 Nov 2021 $1.94 $-0.02 -1.02% 76,541 $1.96 $1.99 $1.94
09 Nov 2021 $1.96 $-0.06 -2.97% 202,036 $2.03 $2.05 $1.96
08 Nov 2021 $2.02 $0.00 0.00% 52,703 $2.03 $2.05 $2.01

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
28 Oct 2021 Lisa Dalton Issued 458 $856
Dividend Reinvestment Plan (DRP).
28 Oct 2021 Wesley Coote Issued 5 $10,668
Dividend Reinvestment Plan (DRP).
28 Oct 2021 Paul Wilson Issued 18 $34,017
Dividend Reinvestment Plan (DRP).
28 Oct 2021 Anthony (Tony) Ganter Issued 4 $7,691
Dividend Reinvestment Plan (DRP).
28 Sep 2021 Paul Wilson Issued 317 $570,731
Rights issue.
28 Sep 2021 Lisa Dalton Issued 7 $14,373
Rights issue.
28 Sep 2021 Wesley Coote Issued 37 $66,855
Rights issue.
28 Sep 2021 Glen Richards Issued 1 $2,070,000
Rights issue.
23 Mar 2021 Wesley Coote Issued 4 $8,452
Dividend Reinvestment Plan (DRP).
23 Mar 2021 Lisa Dalton Issued 328 $561
Dividend Reinvestment Plan (DRP).
23 Mar 2021 Anthony (Tony) Ganter Issued 3 $6,094
Dividend Reinvestment Plan (DRP).
23 Mar 2021 Paul Wilson Issued 15 $25,765
Dividend Reinvestment Plan (DRP).
05 Mar 2021 Paul Wilson Buy 35 $58,750
On-market trade.
05 Mar 2021 Lisa Dalton Buy 5 $9,999
On-market trade.
04 Mar 2021 Paul Wilson Buy 25 $42,250
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Ms Lisa Jane Dalton Non-Executive Director May 2018
Ms Dalton is an experienced director, senior executive and company secretary with experience in the healthcare, medical, utilities, manufacturing, childcare, energy, mining and construction sectors. She has experience in leading teams responsible for strategy, governance, risk management, human resources, communication, stakeholder relations and program management. Lisa has participated in 4 ASX listings in the past 5 years. Lisa has practical experience in fit for purpose governance, risk management, strategic planning and motivating teams to find solutions to complex issues. She is Member of Risk Committee.
Dr Glen Frank Richards Non-Executive ChairmanNon-Executive Director May 2018
Dr Richards is a veterinary surgeon and the founder and former CEO of Greencross Limited. Glen has spent over 20 years. Dr Richards is Member of Risk Committee.
Mr Wesley James Coote Chief Executive OfficerManaging Director Apr 2019
Mr Coote is the former Chief Financial Officer and Company Secretary of Greencross Ltd. Prior to Greencross, Wesley worked in Chartered Accounting where he provided business advice within the health sector, property sector and financial services industry. Wesley joined the Group in December 2015 as Chief Financial Officer and Company Secretary and was appointed Group Managing Director and Chief Executive Officer on 29 April 2019.
Mr Paul David Wilson Non-Executive Director May 2018
Mr Wilson was a co-founder, director and shareholder of Mammoth Pet Holdings Pty Ltd (Pet Barn) prior to the merger with Greencross Limited. Prior to founding Mammoth, Paul was the Chief Operating Officer of ShopFast (sold to Coles in 2003). Paul has worked in the retail industry for 26 years with roles including General Manager of Caltex/Boral JV, Vitalgas. He is Chairman of Risk Committee.
Mr Darren Stewart Executive Director May 2018
Mr Stewart is a registered podiatrist and in 2004 co-founded the My FootDr Business with Greg Dower. In 2015, Darren and Greg saw the opportunity to grow their network of clinics through the acquisition of podiatry clinics. Before merging with Balance Podiatry Group in December 2016. Darren provides strategic leadership and direction to the Feet & Ankles business division.
Mr Anthony (Tony) Peter Ganter Chief Operating OfficerExecutive Director May 2018
Mr Peter Ganter has over 25 years' experience in the management and operation of private physiotherapy and sports medicine clinics and medical teams in professional sport. He possesses knowledge of the professional, administrative and management skills required to operate physiotherapy and sports medicine centres.
Mr Colin Jonathan Kangisser Non-Executive Director Nov 2020
Mr Kangisser is a registered optometrist with over 30 years optical experience. He founded, grew and exited multiple retail chains including Optic Express and Kays Optical prior to holding executive leadership positions with the OPSM Group and founding TOC in 2005.
Mr Christopher Banks Chief Financial OfficerCompany Secretary Apr 2019
-
Christopher Banks Chief Financial OfficerCompany Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
J P Morgan Nominees Australia Pty Limited 10,565,917 11.71%
HSBC Custody Nominees (Australia) Limited 8,434,029 9.35%
My Footdr Holdings Pty Ltd 6,990,694 7.75%
Maximum (NQ) Pty Limited 5,078,764 5.63%
Bridell Pty Limited 5,066,600 5.62%
Chester-LGL Pty Limited 4,333,400 4.80%
DLH Trading Pty Ltd 3,771,465 4.18%
ROM Group Pty Ltd 2,577,232 2.86%
HLA Directors Holdings 2,132,972 2.36%
Willeese Pty Limited 1,208,558 1.34%
GF & LH Richards Super Pty Ltd 1,177,808 1.31%
DPC Investments Pty Ltd 967,317 1.07%
LEGGS Pty Ltd 962,317 1.07%
ZQN Pty Ltd 812,000 0.90%
Mr Christopher Angel & Ms Gina Richman 809,330 0.90%
ABC Investing Pty Ltd 781,310 0.87%
Vassallo Corporate Holdings Pty Ltd 763,654 0.85%
Matthew John Roach 757,267 0.84%
BNP Paribas Nominees Pty Ltd 669,209 0.74%
Mr Anthony Peter Ganter & Ms Deborah Lee Huber 663,212 0.74%

Profile

since

Note